Pirfenidone: Treatment for Idiopathic Pulmonary Fibrosis

0
(0)

Pirfenidone (Esbriet) is an anti-inflammatory and anti-fibrotic drug that reduces inflammation and fibrosis simultaneously. Pirfenidone is an approved pharmacological agent for the treatment of idiopathic pulmonary fibrosis (IPF). In this video, shared by Demystifying Medicine, a youtube channel from McMaster University, learn more about how this drug can be used as a treatment for IPF, its effects and mechanism of action.

Learn more about pulmonary fibrosis: http://bit.ly/1VElTQA

Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

Leave a Comment

Your email address will not be published. Required fields are marked *